Pomeranian Medical University was established in 1948 in Szczecin, Poland. It is referred to as Pomorski Uniwersytet Medyczny in Polish.

During the past decade, Pomorski Uniwersytet Medyczny w Szczecinie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pomorski Uniwersytet Medyczny w Szczecinie" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Department of Health, Generalitat de Catalunya" with 1 trials as a collaborator, "European Commission" with 1 trials as a collaborator, "Göteborg University" with 1 trials as a collaborator and "King's College London" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Pomorski Uniwersytet Medyczny w Szczecinie" are "Bladder Cancer" (2 trials), "Alcoholism" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Endometrial Neoplasms" (1 trials). Many other conditions were trialed in "Pomorski Uniwersytet Medyczny w Szczecinie" in a lesser frequency.

Most popular intervention types in "Pomorski Uniwersytet Medyczny w Szczecinie" are "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apaziquone" (2 trials), "Abiraterone Acetate" (1 trials), "Doxorubicin" (1 trials) and "E-SBI (online screening and brief intervention)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pomorski Uniwersytet Medyczny w Szczecinie" are 3 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pomorski Uniwersytet Medyczny w Szczecinie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pomorski Uniwersytet Medyczny w Szczecinie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pomorski Uniwersytet Medyczny w Szczecinie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Pomorski Uniwersytet Medyczny w Szczecinie has several departments that took part in Clinical trials: "Departmen of Neurology" - 3 trials, "Pomeranian Medical University, Department of Orthodontics" - 2 trials